These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8098239)

  • 1. Dose equivalence of drugs for asthma.
    Fuller RW
    BMJ; 1993 Apr; 306(6884):1066-7. PubMed ID: 8098239
    [No Abstract]   [Full Text] [Related]  

  • 2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol xinafoate in asthma.
    Palmer JB; Oxford JM
    JAMA; 1994 Nov 23-30; 272(20):1575-6. PubMed ID: 7966861
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose equivalence of drugs for asthma.
    Lötvall J; Svedmyr N
    BMJ; 1993 Apr; 306(6884):1066. PubMed ID: 8490515
    [No Abstract]   [Full Text] [Related]  

  • 5. Dose equivalence of drugs for asthma.
    Doull IJ; Patel SR
    BMJ; 1993 Apr; 306(6884):1066. PubMed ID: 8490514
    [No Abstract]   [Full Text] [Related]  

  • 6. Several studies have shown salmeterol to be more potent than salbutamol for systemic effects.
    Bennett J; Tattersfield AE
    BMJ; 1997 Jul; 315(7100):121. PubMed ID: 9240063
    [No Abstract]   [Full Text] [Related]  

  • 7. Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma.
    Durham S
    Eur Respir J; 1999 Aug; 14(2):249-50. PubMed ID: 10515396
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchodilator reversibility to albuterol predicts bronchodilator response to salmeterol.
    Lipworth BJ; Jackson CM
    Chest; 2002 Apr; 121(4):1382. PubMed ID: 11948092
    [No Abstract]   [Full Text] [Related]  

  • 9. Bronchodilator treatment in asthma: continuous or on demand?
    Hilton CJ; Fuller RW
    BMJ; 1992 Jan; 304(6819):121. PubMed ID: 1346579
    [No Abstract]   [Full Text] [Related]  

  • 10. The expanding role of long-acting beta-agonists.
    Donohue JF
    Chest; 2000 Aug; 118(2):283-5. PubMed ID: 10936111
    [No Abstract]   [Full Text] [Related]  

  • 11. [More asthma death cases with beta-2-antagonists: with inhaled corticosteroids on the safe side?].
    Wepner U
    MMW Fortschr Med; 2007 Dec; 149(49-50):20. PubMed ID: 18240436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of salmeterol in patients with allergic bronchial asthma].
    Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C
    Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bronchial asthma -- to set the measuring rod higher. Combination therapy defines asthma control anew].
    MMW Fortschr Med; 2003 Nov; 145(46):46-7. PubMed ID: 14699833
    [No Abstract]   [Full Text] [Related]  

  • 14. Can beta agonists cause dilated cardiomyopathy?
    Choudhary AS; Robinson GM
    Heart Lung Circ; 2009 Oct; 18(5):367-9. PubMed ID: 19081299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group.
    Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML
    Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
    Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
    Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIASMA: asthma exacerbation reduction with salmeterol.
    Shrewsbury S; Pyke S
    Chest; 2002 Mar; 121(3):1002-4. PubMed ID: 11888994
    [No Abstract]   [Full Text] [Related]  

  • 18. Paradoxical bronchoconstriction in asthmatic patients after salmeterol by metered dose inhaler.
    Wilkinson JR; Roberts JA; Bradding P; Holgate ST; Howarth PH
    BMJ; 1992 Oct; 305(6859):931-2. PubMed ID: 1360855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combination of beta-1 agonist and corticosteroid is advantageous not only in asthma. COPD patients spared exacerbations].
    MMW Fortschr Med; 2002 Oct; 144(44):55. PubMed ID: 12494604
    [No Abstract]   [Full Text] [Related]  

  • 20. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.